Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. - Wikidata - awgldk - TriplyDB

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

http://www.wikidata.org/entity/Q33396902

about

The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.Defective regulatory B-cell compartment in patients with immune thrombocytopenia CD16+ monocytes control T-cell subset development in immune thrombocytopenia.B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.Immune dysregulation in immune thrombocytopenia.Pathophysiology and management of primary immune thrombocytopenia.Cellular immune dysfunction in immune thrombocytopenia (ITP).Contemporary treatment of immune thrombocytopenia.In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.Advances in the pathophysiology of primary immune thrombocytopenia.Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia.Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome.Rituximab efficiently depletes B cells in lung tumors and normal lung tissue.A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.Plasma cell survival in the absence of B cell memory.A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.Emerging Concepts in Immune Thrombocytopenia.

P2860

Q28068881-A80BA2AE-4A9D-49C2-A4B4-FEB5478AA3C4 Q33401624-EF8900D4-46F3-45AD-A9CF-62164E740F97 Q33402659-3E494960-89DB-4F31-9B90-C9638C3083C3 Q33402944-5C926F8D-68A6-4FA1-B335-988BC502F026 Q33404838-6E9B0A1E-06B5-4F1D-8999-080FDC858C37 Q33407649-4EA301F6-D60B-46AE-9D2B-CB6654EE748B Q33407942-1F49090B-CB40-4BC8-891A-8A490B3F4AEB Q33409710-D646F9E7-8272-438D-B4BE-A94EA64A8D63 Q33410653-A903B29D-6303-466D-88EA-24591C292CE9 Q33417826-49FAA5D3-CB0A-42BE-A4CD-0E962E3F77DD Q33419712-7767E9FD-3CFF-4267-872F-BB1835CC3869 Q33426961-0E181315-382A-47C3-87A7-CEE78CD18360 Q33435590-6A5B9FA4-D535-439E-8780-A7AAFE0F8213 Q33436930-F64E2432-8A6F-4313-9CD5-71DDE909B964 Q33438855-C3D38836-B353-4046-AC82-5320A34BF4D9 Q33439412-5B87536C-760B-4703-9FF2-B6A3591F3266 Q33441008-806E2CF8-F039-41E8-A4A4-AE948FFA1C0A Q33798060-20486389-A2D8-41B7-BF27-4A1D152E0B7C Q33838871-5FBD14F5-A447-4AAF-AD1D-17239A958351 Q34398374-4319F613-6400-4243-9BAE-0ED983DC4AB4 Q34979610-BF68DA95-F061-4945-A642-76FF05A91D4A Q36085401-67BDAFF4-4A66-4CD9-8F5F-905FAE74EF00 Q37117624-59E7EC8C-7230-434B-869B-B2BCDAE4BF3B Q38097170-7712933B-66B9-48AB-A216-A3A0E8B959D3 Q38839087-214AF4B3-295A-4CE7-B864-FAA9C57821AD Q39680704-4D922B53-8F1D-44F7-9CDE-7CC4976FC420 Q42568871-6F93C2C3-1457-499F-93AC-F78949F81913 Q47113778-C04B254F-32F4-4615-B76B-91D221DEF9D7 Q50905754-A2A1AD0D-A739-4506-AC69-8FF81CD16B2E Q54211951-89E126E0-E3B6-4252-98E2-5B1999A3FA57

P2860

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

http://www.wikidata.org/entity/Q33396902

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@ast

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@en

type

label

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@ast

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@en

prefLabel

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@ast

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@en

P1433

Q33396902-358D8885-757D-4940-B011-DF92B26305E3

P1476

Q33396902-2ADD1CB4-1AF4-492E-BBC3-3512BCEC1944

P2093

Q33396902-54ED34F7-E385-4D84-9BAA-84E300598443

Q33396902-6A87DAF0-9133-4B46-A1AA-C0F2A9E394A4

Q33396902-7F4A41ED-A1C9-4BD7-8444-CD3009D9F0B3

Q33396902-80132726-B842-48C3-BAD5-54363F46594D

Q33396902-80F58679-F34F-4BAC-A96A-3B9F0B045DE9

Q33396902-9A6D4DAB-705B-48F1-B934-6A4FFB9A8F43

Q33396902-AA238158-E3AB-4F24-BBDB-FEE4BCF7BB37

Q33396902-AC5C9A4E-D87E-4068-8C25-0A95EE07A9C6

Q33396902-C1803467-0EBA-4F1A-95CA-7FB7F629879A

Q33396902-C3656DCE-C3F9-4E31-9731-5D385FE41313

P2860

Q33396902-05AF9FE3-D97E-4255-8973-B5F92EE05662

Q33396902-11145EDB-9F84-49C2-A23D-3AF36AD1C9B1

Q33396902-1296A5F7-E048-4C43-B30E-3C24461DE72F

Q33396902-1608CA94-8C5C-4109-B656-97613BD539D4

Q33396902-16C145FA-F40E-43A2-93F8-D0119BB8DA07

Q33396902-1844A379-3F85-4D09-BE0A-1C606AADB683

Q33396902-1EB77855-721B-49D2-A647-74462CF9BC9B

Q33396902-25171B5F-DEE2-4A38-B87F-994294ACBDBA

Q33396902-258D35BE-8AD0-4813-BC9F-E638124FA5DF

Q33396902-26ED3B71-9509-4808-BAE4-688E49B571DC

P304

Q33396902-086046E2-8E96-4C37-AE44-6C0BDC984C63

P31

Q33396902-DEEF283E-B8ED-46C7-AF84-3660C7854BDC

P356

Q33396902-E49E630A-6FEB-4841-A555-E9E9E404541A

P407

Q33396902-4388C017-2630-49B2-9C9D-C3AF19F16D5B

P433

Q33396902-DFF62D65-349A-4548-A8ED-B51FF2E5181D

P478

Q33396902-FF7B4DDF-CB1F-478C-A940-8458E432A64F

P50

Q33396902-75FC4C04-B928-4861-84EA-088B7CAF4017

Q33396902-A3BF382B-1660-4B7C-AB43-C22F65E3401A

P577

Q33396902-888009E5-3ECC-45BB-8551-C3841AF35852

P5875

Q33396902-C2B1B964-14AE-4479-960D-D8065D96B10C

P698

Q33396902-6A435908-FE5A-499C-9E08-07217C304B22

P921

Q33396902-6608A53A-25A9-4D28-98EE-49ECBF6E539D

P932

Q33396902-6B43146F-3D40-47D8-9F1A-3474FA8D3B85

P356

BLOOD-2011-03-344051

P1433

P1476

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

@en

P2093

Bernard Lorcerie

http://www.w3.org/2001/XMLSchema#string

Emmanuel Katsanis

http://www.w3.org/2001/XMLSchema#string

Jennifer Fraszczak

http://www.w3.org/2001/XMLSchema#string

Julien Guy

http://www.w3.org/2001/XMLSchema#string

Laurent Martin

http://www.w3.org/2001/XMLSchema#string

Malika Trad

http://www.w3.org/2001/XMLSchema#string

Marc Maynadié

http://www.w3.org/2001/XMLSchema#string

Marion Ciudad

http://www.w3.org/2001/XMLSchema#string

Maxime Samson

http://www.w3.org/2001/XMLSchema#string

Nicolas Cheynel

http://www.w3.org/2001/XMLSchema#string

P2860

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation.

The incidence of idiopathic thrombocytopenic purpura in adults increases with age.

The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

Structure of the spleen in idiopathic thrombocytopenic purpura.

P304

4394-4400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-03-344051

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Bernard Bonnotte

P577

2011-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51604055

http://www.w3.org/2001/XMLSchema#string

P698

21876120

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

3204911

http://www.w3.org/2001/XMLSchema#string